|
|
| (125 intermediate revisions not shown) |
| Line 1: |
Line 1: |
| - | {{:Team:Evry/template_v1}}
| |
| - | <html>
| |
| | | | |
| - | <div style="text-align:center"><h1> Our team </h1></div>
| |
| - |
| |
| - | <div style="text-align:center"><b>Here our fucking faces<b></div>
| |
| - |
| |
| - | <h1>Instructors</h1>
| |
| - |
| |
| - | <table id="team" cellspacing="10">
| |
| - | <tr>
| |
| - | <td>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/6/68/Photo_Alfonso.jpeg" alt="alfonso" align="left" height="150px"/>
| |
| - | <h3>Dr. Alfonso Jaramillo</h3>
| |
| - | <i>Group leader of the Synth-Bio team at iSSB</i><br/>
| |
| - | <a href="mailto:alfonso.jaramillo@gmail.com">Contact</a><br/><br/>
| |
| - | <p>
| |
| - | After a PhD in theoretical physics, he was converted to synthetic biology for over 10 years. He gained international recognition in this field. He is now the team director of the Bio-Synth iSSB, working on the design, synthesis and characterization of biological regulatory artificial pathways. He is also one of the main teachers of the mSSB (synthetic and systematic biology master). Alfonso Jaramillo will be our main supervisor. He led Valencia iGEM team in 2006, and participated in the supervision of Valencia's and Paris' teams.
| |
| - | </p>
| |
| - | </td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/d/d4/Photo_Andrew.jpeg" alt="andrew" align="left" height="150px"/>
| |
| - | <h3>Dr. Andrew Tolonen</h3>
| |
| - | <i>Group leader at Genoscope</i><br/>
| |
| - | <a href="mailto:atolonen@gmail.com">Contact</a><br/><br/>
| |
| - | <p>
| |
| - | After a PhD in genetics and genomics of cyanobacteria at MIT and a post-doc in the team of George Church at Harvard, one of the largest synthetic biology laboratories in the world, he is now a researcher at Genoscope in Evry. His work focuses on the manufacture of biofuels by cyanobacteria. Andrew Tolonen attends the our team in the selection and construction of the project. He participated in the supervision of Harvard iGEM teams during his post-PhD.
| |
| - | </p>
| |
| - | </td>
| |
| - | </tr>
| |
| - | <tr>
| |
| - | <td>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/d/d8/Photo_Nicolas.jpg" alt="nicolas" align="left" height="150px"/>
| |
| - | <h3>Dr. Nicolas Pollet</h3>
| |
| - | <i>Group leader of the Metamorphosis team at iSSB</i><br/>
| |
| - | <a href="mailto:nicolas.pollet@issb.genopole.fr">Contact</a><br/><br/>
| |
| - | <p>
| |
| - | After a PhD in developmental physiology at INSERM, he was a Marie Curie post-doctoral fellow at the German Cancer Research Institute in Heidelberg. He is now a CNRS senior scientist, head of the Metamorphosys group at iSSB working in genomics and systems biology using the Xenopus frog model. Nicolas Pollet will participate to IGEM as supervisor for the first time this year.
| |
| - | </p>
| |
| - | </td>
| |
| - | </tr>
| |
| - | </table>
| |
| - |
| |
| - | <script type="text/javascript">writeFooter()</script>
| |
| - | </html>
| |
"
